Effect of thrombin inhibitors on positive feedback in the coagulation cascade
- 196 Downloads
The coagulation cascade is a series of sequential reactions of limited proteolysis of protein factors resulting in generation of thrombin. Thrombin mediates both positive and negative feedback in regulating this cascade by taking part in activation of several factors. Some thrombin inhibitors, by affecting positive feedback, inhibit generation of thrombin itself. In the current study, we used two thrombin inhibitors: argatroban, a low molecular weight reversible competitive inhibitor that binds to the active site, and bivalirudin, a bivalent oligopeptide that blocks the active site and binding center of protein substrates (exosite I). Appearance rate and total amount of thrombin were measured in a thrombin generation assay (TGA) using a fluorescent substrate. We found that argatroban slows the appearance of thrombin and lowers its amount. Bivalirudin also slows appearance of thrombin, but it does not decrease its amount, perhaps because the region being bound to the active site undergoes hydrolysis so that the inhibitor stops binding to thrombin. Many reactions of the coagulation cascade proceed on the surface of phospholipid micelles (PLMs). In the case of argatroban, PLMs do not affect the results of the TGA, whereas for bivalirudin they lower its inhibitory activity. It seems that PLMs stabilize protein complexes (wherein thrombin exosite I is hindered) mediating positive feedback in the coagulation cascade, e.g. complexes of thrombin with factor V and VIII.
Key wordsthrombin thrombin generation assay argatroban bivalirudin
coagulation factors II/V/VII/VIII/IX/X/XI/XII/XIII (activated)
thrombin generation assay
Unable to display preview. Download preview PDF.
- 8.Von dem Borne, P. A., Meijers, J. C., and Bouma, B. N. (1995) Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis, Blood, 86, 3035–3042.Google Scholar
- 11.Bode, W., Mayr, I., Baumann, U., Huber, R., Stone, S. R., and Hofsteenge, J. (1989) The refined 1.9 Å crystal structure of human alpha-thrombin: interaction with D-Phe-Pro-Arg chloromethylketone and significance of the TyrPro-Pro-Trp insertion segment, EMBO J., 8, 3467.PubMedPubMedCentralGoogle Scholar
- 26.Tanaka, K. A., Szlam, F., Sun, H. Y., Taketomi, T., and Levy, J. H. (2007) Thrombin generation assay and vis-coelastic coagulation monitors demonstrate differences in the mode of thrombin inhibition between unfractionated heparin and bivalirudin, Anesth. Analg., 105, 933–939.CrossRefPubMedGoogle Scholar
- 29.Yun, T. H., Baglia, F. A., Myles, T., Navaneetham, D., Lopez, J. A., Walsh, P. N., and Leung, L. L. (2003) Thrombin activation of factor XI on activated platelets requires the interaction of factor XI and platelet glycoprotein Iba with thrombin anion-binding exosites I and II, respectively, J. Biol. Chem., 278, 48112–48119.CrossRefPubMedGoogle Scholar
- 32.DiMaio, J., Gibbs, B., Lefebvre, J., Konishi, Y., Munn, D., Yue, S. Y., and Hornberger, W. (1992) Synthesis of a homologous series of ketomethylene arginyl pseudodipep-tides and application to low molecular weight hirudin-like thrombin inhibitors, J. Med. Chem., 35, 3331–3341.CrossRefPubMedGoogle Scholar